Collagen crosslinking with riboflavin and ultraviolet-A in eyes with pseudophakic bullous keratopathy

Journal of Cataract and Refractive Surgery

Volumn 36, Issue 2, 2010, Pages 273-276

  Ghanem, Ramon C ^a   Santhiago, Marcony R ^a   Berti, Thaís B ^a   Thomaz, Sergio ^a   Netto, Marcelo V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DEXTRAN; RIBOFLAVIN;

ADULT; AGED; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTACT LENS; CORNEA EDEMA; CORNEA EPITHELIUM; CORNEA OPACITY; CORNEA THICKNESS; CROSS LINKING; EYE DISCOMFORT; EYE PAIN; FEMALE; HUMAN; KERATOPATHY; KERATOPROSTHESIS; MALE; PAIN ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOPHAKIA; PSEUDOPHAKIC BULLOUS KERATOPATHY; RADIATION EXPOSURE; THERAPY EFFECT; ULTRAVIOLET A RADIATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; COLLAGEN; CORNEAL DISEASES; CORNEAL STROMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; PSEUDOPHAKIA; RIBOFLAVIN; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 75449086655     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2009.07.041     Document Type: Article

References (13)

1. Shimazaki J., Amano S., Uno T., Maeda N., and Yokoi N. National survey on bullous keratopathy in Japan; the Japan Bullous Keratopathy Study Group. Cornea 26 (2007) 274-278
2. Brady S.E., Rapuano C.J., Arentsen J.J., Cohen E.J., and Laibson P.R. Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988. Am J Ophthalmol 108 (1989) 118-122
3. Al-Yousuf N., Mavrikakis I., Mavrikakis E., and Daya S.M. Penetrating keratoplasty: indications over a 10 year period. Br J Ophthalmol 2004 88 (2009) 998-1001. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1772260&blobty pe =pdf Accessed October 8l, 2009
4. Al-Towerki A.-E., Gonnah E.-S., Al-Rajhi A., and Wagoner M.D. Changing indications for corneal transplantation at the King Khaled Eye Specialist Hospital. Cornea 2004 23 (1983-2002) 584-588
5. Dobbins K.R.B., Price Jr. F.W., and Whitson W.E. Trends in the indications for penetrating keratoplasty in the Midwestern United States. Cornea 19 (2000) 813-816
6. Rao G.N., Aquavella J.V., Goldberg S.H., and Berk S.L. Pseudophakic bullous keratopathy; relationship to preoperative corneal endothelium status. Ophthalmology 91 (1984) 1135-1140
7. Wollensak G., Spoerl E., and Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135 (2003) 620-627
8. Wollensak G., Sporl E., and Seiler T. Behandlung von Keratoconus durch Kollagenvernetzung. [Treatment of keratoconus by collagen cross linking]. Ophthalmologe 100 (2003) 44-49
9. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17 (2006) 356-360
10. Wollensak G., Spoerl E., and Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 29 (2003) 1780-1785
11. Wollensak G., Aurich H., Pham D.-T., and Wirbelauer C. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg 33 (2007) 516-521
12. Krueger R.R., Ramos-Esteban J.C., and Kanellopoulos A.J. Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous keratopathy: laboratory investigation and first clinical case. J Refract Surg 24 (2008) S730-S736
13. Wollensak G., Aurich H., Wirbelauer C., and Pham D- T. Potential use of riboflavin/UVA cross-linking in bullous keratopathy. Ophthalmic Res 41 (2009) 114-117